Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Danone sought to gather and compare real-life data on parenting with both full-term and pre-term infants.
Data was collected virtually through a chat function in the app that asked parents daily questions about stress levels, infant nutrition and sleep.
• Full recruitment completed 25% ahead of plan.
• Disparities in stress levels between the two groups revealed the need for more support for parents of pre-term infants.
• 80% of tired parent participants rated the app as “easy to use.”
A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.
A biopharmaceutical company is seeking a Phase IV clinical trial to confirm the safety and efficacy of its ADHD therapeutic on a more real-world population. Phases I-III included narrow inclusion and exclusion criteria.